Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Dec 21, 2023 (3 years ago)

8.4 % Sodium Bicarbonate Injection

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter; identified as glass

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).

Affected NDCs 0409-6637-14 0409-6637-24

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sodium Bicarbonate
NDC 00409-6637
84 mg/mL Injection, Solution
Intravenous
Hospira, Inc. Rx
Recalling firm
Pfizer Inc.
NDC code
0409-6637-24
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0234-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other recalls by Pfizer Inc.

All 2023 recalls

Other particulate / foreign matter recalls from 2023

All particulate / foreign matter recalls